Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.77 USD | +3.51% | -1.67% | +1.72% |
02/05 | XWELL, Inc. Introduces IV Hydration Drip Therapy at Miami International Airport | CI |
16/04 | XWELL, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Valuation
Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Capitalization 1 | 5.389 | 10.23 | 111.9 | 212.8 | 30.2 | 7.273 |
Enterprise Value (EV) 1 | 11.37 | 23.3 | 37.47 | 121.1 | 2.121 | -4.683 |
P/E ratio | -0.12 x | -0.16 x | -0.58 x | 67.3 x | -1.04 x | -0.26 x |
Yield | - | - | - | - | - | - |
Capitalization / Revenue | 0.11 x | 0.22 x | 13.3 x | 2.89 x | 0.54 x | 0.24 x |
EV / Revenue | 0.23 x | 0.49 x | 4.47 x | 1.64 x | 0.04 x | -0.16 x |
EV / EBITDA | -3.92 x | -6.94 x | -2.19 x | 14.9 x | -0.11 x | 0.27 x |
EV / FCF | 9.09 x | 9.46 x | -2.51 x | 14.6 x | -0.12 x | 0.56 x |
FCF Yield | 11% | 10.6% | -39.8% | 6.84% | -841% | 179% |
Price to Book | 0.6 x | -1.67 x | 1.44 x | 2.21 x | 0.76 x | 0.56 x |
Nbr of stocks (in thousands) | 28.8 | 253 | 4,701 | 5,266 | 4,162 | 4,180 |
Reference price 2 | 187.2 | 40.49 | 23.80 | 40.40 | 7.258 | 1.740 |
Announcement Date | 01/04/19 | 20/04/20 | 31/03/21 | 31/03/22 | 17/04/23 | 16/04/24 |
Income Statement Evolution (Annual data)
Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Net sales 1 | 49.64 | 47.42 | 8.385 | 73.73 | 55.94 | 30.11 |
EBITDA 1 | -2.898 | -3.358 | -17.14 | 8.145 | -19.12 | -17.23 |
EBIT 1 | -10.3 | -9.482 | -22.35 | 4.944 | -24.55 | -19.3 |
Operating Margin | -20.74% | -20% | -266.52% | 6.71% | -43.89% | -64.08% |
Earnings before Tax (EBT) 1 | -35.91 | -20.68 | -92.22 | 2.949 | -32.57 | -27.99 |
Net income 1 | -37.2 | -21.22 | -90.49 | 3.349 | -32.84 | -27.74 |
Net margin | -74.94% | -44.76% | -1,079.17% | 4.54% | -58.7% | -92.14% |
EPS 2 | -1,536 | -259.8 | -41.03 | 0.6000 | -7.012 | -6.644 |
Free Cash Flow 1 | 1.251 | 2.462 | -14.92 | 8.285 | -17.84 | -8.381 |
FCF margin | 2.52% | 5.19% | -177.92% | 11.24% | -31.89% | -27.84% |
FCF Conversion (EBITDA) | - | - | - | 101.72% | - | - |
FCF Conversion (Net income) | - | - | - | 247.39% | - | - |
Dividend per Share | - | - | - | - | - | - |
Announcement Date | 01/04/19 | 20/04/20 | 31/03/21 | 31/03/22 | 17/04/23 | 16/04/24 |
Income Statement Evolution (Quarterly data)
Fiscal Period: December | 2021 Q3 | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 |
---|---|---|---|---|---|---|---|---|---|
Net sales 1 | 26.77 | 29.36 | 24 | 13.6 | 10.7 | 7.558 | 7.063 | 8.175 | 7.468 |
EBITDA 1 | 8.699 | 4.463 | 0.356 | -4.998 | -4.567 | -6.142 | -4.957 | -3.487 | -3.104 |
EBIT 1 | 7.057 | 2.256 | -2.451 | -7.767 | -7.654 | -13.29 | -6.288 | -4.724 | -3.694 |
Operating Margin | 26.36% | 7.68% | -10.21% | -57.12% | -71.53% | -175.85% | -89.03% | -57.79% | -49.46% |
Earnings before Tax (EBT) 1 | 6.682 | 1.897 | -2.762 | -7.925 | -7.676 | -14.21 | -5.829 | -5.679 | -9.978 |
Net income 1 | 5.597 | 3.275 | -4.3 | -7.918 | -7.2 | -13.46 | -5.509 | -5.73 | -9.918 |
Net margin | 20.91% | 11.16% | -17.92% | -58.23% | -67.29% | -178.05% | -78% | -70.09% | -132.81% |
EPS 2 | 1.000 | 0.6000 | -0.8000 | -1.600 | -1.600 | -3.000 | -1.400 | -1.400 | -2.380 |
Dividend per Share | - | - | - | - | - | - | - | - | - |
Announcement Date | 15/11/21 | 15/03/22 | 16/05/22 | 15/08/22 | 10/11/22 | 17/04/23 | 15/05/23 | 14/08/23 | 14/11/23 |
Balance Sheet Analysis
Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Net Debt 1 | 5.98 | 13.1 | - | - | - | - |
Net Cash position 1 | - | - | 74.4 | 91.7 | 28.1 | 12 |
Leverage (Debt/EBITDA) | -2.063 x | -3.893 x | - | - | - | - |
Free Cash Flow 1 | 1.25 | 2.46 | -14.9 | 8.29 | -17.8 | -8.38 |
ROE (net income / shareholders' equity) | -121% | -387% | -237% | 3.21% | -44.1% | -81.3% |
ROA (Net income/ Total Assets) | -13.4% | -20% | -21.2% | 2.68% | -15.5% | -22% |
Assets 1 | 277 | 106.2 | 427.1 | 124.9 | 211.5 | 125.9 |
Book Value Per Share 2 | 310.0 | -24.20 | 16.50 | 18.30 | 9.590 | 3.110 |
Cash Flow per Share 2 | 116.0 | 8.470 | 19.10 | 20.80 | 4.570 | 2.020 |
Capex 1 | 3.03 | 2.28 | 3.97 | 4.28 | 6.46 | 1.91 |
Capex / Sales | 6.11% | 4.8% | 47.33% | 5.81% | 11.56% | 6.33% |
Announcement Date | 01/04/19 | 20/04/20 | 31/03/21 | 31/03/22 | 17/04/23 | 16/04/24 |
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
1st Jan change | Capi. | |
---|---|---|
+1.72% | 7.4M | |
-13.17% | 574M | |
+48.01% | 498M | |
-25.45% | 391M | |
+6.68% | 278M | |
-19.54% | 212M | |
-23.87% | 97.41M | |
-4.95% | 81.25M | |
-22.13% | 65.77M | |
-12.41% | 65.5M |
- Stock Market
- Equities
- XWEL Stock
- Financials XWELL, Inc.